🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementGLP-1 and menstrual irregularity — looking for input

GLP-1 and menstrual irregularity — looking for input

claudia_zurich Sat, Dec 28, 2024 at 5:47 PM 16 replies 1,709 viewsPage 1 of 4
This thread is more than 17 months old. Information may be outdated. Consider searching for more recent discussions.
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Dec 28, 2024 at 5:47 PM#1

Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

What I actually want to know is whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out.

I would rather have one careful answer than five confident ones.

39 9emma_london, tammy_FL, Dr.LipidDallas and 36 others
Reply Quote Save Share Report
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Dec 28, 2024 at 5:56 PM#2

This one has a reasonably settled answer, so here it is. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

That is the short version; the long version is somebody else's post.

38 8sarah_TO, wendy_avl, jason_paloalto and 35 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Dec 28, 2024 at 6:05 PM#3
JessicaH_TX said:
The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the…

That is correct as far as it goes, and here is where it stops going. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

37 7Dr.PulmRoch, maya_sedona, stefan_berlin and 34 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Dec 28, 2024 at 6:14 PM#4
claudia_zurich said:
Nausea arrived on day two of each dose step, lasted about four days, and disappeared entirely by the second week — until the step where it did not.

This matches mine closely enough to be worth saying so. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Dec 28, 2024 at 8:14 PM
36 6TomTeleRx, DoseLogDan, SleepFixSam and 33 others
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Dec 28, 2024 at 7:02 PM#5

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Dec 28, 2024 at 9:02 PM
35 5NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 32 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register